UK firm to launch pioneering stem cell trial
By Ben Hirschler
LONDON (Reuters) - A British biotechnology company, working with a team of doctors in Scotland, is to launch a pioneering clinical trial to assess whether stem cell therapy can help patients left disabled by stroke.
ReNeuron Group Plc said on Sunday it had received approval from the UK Medicines and Healthcare Products Regulatory Agency to commence the clinical trial using its fetal stem cells.
The move is a victory for the company, which has so far failed to win approval for similar tests from U.S. regulators. It also represents a boost for Britain’s position as a leader in developing stem cell treatments.
The first patients are expected to be recruited into the Phase I program at the Institute of Neurological Sciences, Southern General Hospital, Glasgow, in the second quarter of this year.
Continue reading - Reuters Health
